Researchers will highlight new injection systems, wearable devices and testing services supporting high-viscosity biologics, ...

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, ...

— Novel, third-generation PCSK9 inhibitor designed to help patients more easily achieve lifelong cholesterol goals with robust and sustained LDL-C reductions of 50% or more — — Approved for adults ...

The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and non-lactating dairy cattle.